Cofactors and markers of disease progression in human immunodeficiency virus infection

被引:4
|
作者
Sabin, CA [1 ]
Mocroft, A [1 ]
Lepri, AC [1 ]
Phillips, AN [1 ]
机构
[1] Royal Free Hosp, Sch Med, Dept Primary Care & Populat Sci, London NW3 2PF, England
关键词
CCR-5; receptor; CD4 cell count; cofactors; markers of progression; prognostic markers; viral load;
D O I
10.1111/1467-985X.00097
中图分类号
O1 [数学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 0701 ; 070101 ;
摘要
The identification of factors which are related to human immunodeficiency virus (HIV) disease progression, either by a direct interaction with HIV to increase the rate of disease progression or by providing an indication of an infected individual's likely prognosis, can have great value when understanding HIV pathogenesis and in the development of novel therapeutic approaches. This paper describes the roles of the CD4 cell count and the viral load as markers of disease progression and discusses the recent findings on chemokine receptors in HIV infection. Our current knowledge on these factors is summarized and unresolved statistical issues are highlighted.
引用
收藏
页码:177 / 189
页数:13
相关论文
共 50 条
  • [1] COFACTORS IN THE LATENCY AND PROGRESSION OF HUMAN-IMMUNODEFICIENCY-VIRUS DISEASE
    CUNNINGHAMRUNDLES, S
    HILGARTNER, MW
    TARTER, TH
    KOIDE, SH
    JOURNAL OF IMMUNOLOGICAL RESEARCH, 1991, 3 (01): : 31 - 36
  • [2] Clinical Reactivations of Herpes Simplex Virus Type 2 Infection and Human Immunodeficiency Virus Disease Progression Markers
    Aumakhan, Bulbulgul
    Gaydos, Charlotte A.
    Quinn, Thomas C.
    Beyrer, Chris
    Benning, Lorie
    Minkoff, Howard
    Merenstein, Daniel J.
    Cohen, Mardge
    Greenblatt, Ruth
    Nowicki, Marek
    Anastos, Kathryn
    Gange, Stephen J.
    PLOS ONE, 2010, 5 (03):
  • [3] Otolaryngologic disease progression in children with human immunodeficiency virus infection
    Chen, AY
    Ohlms, LA
    Stewart, MG
    Kline, MW
    ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 1996, 122 (12) : 1360 - 1363
  • [4] Progression of human immunodeficiency virus infection in patients with tuberculosis disease
    Leroy, V
    Salmi, LR
    Dupon, M
    Sentilhes, A
    TexierMaugein, J
    Dequae, L
    Dabis, F
    Salamon, R
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 1997, 145 (04) : 293 - 300
  • [5] Immunological markers of disease progression in patients infected with the human immunodeficiency virus
    Pascale, JM
    Isaacs, MD
    Contreras, P
    Gomez, B
    Lozano, L
    Austin, E
    DeMartin, MC
    Gregory, RL
    McLaughlin, GL
    Amador, A
    CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1997, 4 (04) : 474 - 477
  • [6] MYCOPLASMAS AS COFACTORS IN INFECTION DUE TO THE HUMAN-IMMUNODEFICIENCY-VIRUS
    MONTAGNIER, L
    BLANCHARD, A
    CLINICAL INFECTIOUS DISEASES, 1993, 17 : S309 - S315
  • [7] MARKERS PREDICTING PROGRESSION OF HUMAN IMMUNODEFICIENCY VIRUS-RELATED DISEASE
    TSOUKAS, CM
    BERNARD, NF
    CLINICAL MICROBIOLOGY REVIEWS, 1994, 7 (01) : 14 - 28
  • [8] Association of sexually transmitted diseases and infection with the human immunodeficiency virus: Biological cofactors and markers of behavioural interventions
    Quinn, TC
    INTERNATIONAL JOURNAL OF STD & AIDS, 1996, 7 : 17 - 24
  • [9] Encephalopathy and progression of human immunodeficiency virus disease in a cohort of children with perinatally acquired human immunodeficiency virus infection
    Cooper, ER
    Hanson, C
    Diaz, C
    Mendez, H
    Abboud, R
    Nugent, R
    Pitt, J
    Rich, K
    Rodriguez, EM
    Smeriglio, V
    JOURNAL OF PEDIATRICS, 1998, 132 (05): : 808 - 812
  • [10] Valproic acid does not affect markers of human immunodeficiency virus disease progression
    Beau M. Ances
    Scott Letendre
    Maria Buzzell
    Jennifer Marquie-Beck
    Deborah Lazaretto
    Thomas D. Marcotte
    Igor Grant
    Ronald J. Ellis
    Journal of NeuroVirology, 2006, 12 : 403 - 406